Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin adjunct therapy in mild-to-moderate ulcerative colitis
IRCT20181006041252N20Phase 3Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in autoimmune colitis comparing Metformin adjunct arm with Placebo control arm (2 arms). Primary endpoint: Disease activity index. Started Apr 2017; status: completed.
02
Drugs
metformin
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on IRCT20181006041252N20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181006041252N20.